{"tab": "twitter", "queriedAt": "2020-05-21 20:31:08", "citation_id": "57249592", "twitter": {"1107814318920196097": {"datetime": "2019-03-19 01:21:30", "followers": "1,504", "author": "@matsui_kota", "content_summary": "RT @StatMLPapers: On Multi-Armed Bandit Designs for Phase I Clinical Trials. (arXiv:1903.07082v1 [https://t.co/zjV5HgYw5a]) https://t.co/jd\u2026"}, "1108116011805335552": {"datetime": "2019-03-19 21:20:19", "followers": "656", "author": "@crude2refined", "content_summary": "RT @StatMLPapers: On Multi-Armed Bandit Designs for Phase I Clinical Trials. (arXiv:1903.07082v1 [https://t.co/zjV5HgYw5a]) https://t.co/jd\u2026"}, "1108008185787547648": {"datetime": "2019-03-19 14:11:51", "followers": "749", "author": "@arxivml", "content_summary": "\"On Multi-Armed Bandit Designs for Phase I Clinical Trials\", Maryam Aziz, Emilie Kaufmann, Marie-Karelle Riviere https://t.co/4nXLvW8dyE"}, "1137013151524970504": {"datetime": "2019-06-07 15:07:14", "followers": "229", "author": "@CancersUnknown", "content_summary": "Wondering your thoughts on innovative Phase 1 designs - https://t.co/1k0WtDIg62 @VPrasadMDMPH @Aiims1742 @PanCAN @CpcrMsk @Simple_Trials"}, "1107812861789827072": {"datetime": "2019-03-19 01:15:43", "followers": "9,566", "author": "@StatMLPapers", "content_summary": "On Multi-Armed Bandit Designs for Phase I Clinical Trials. (arXiv:1903.07082v1 [https://t.co/zjV5HgYw5a]) https://t.co/jdiK6xN3ko"}}, "completed": "1"}